The main constituent of GCIs is α-synuclein (αsyn), as such, classifying MSA as part of the α-synucleinopathy group of diseases, which also includes Parkinson's disease (PD) and dementia with Lewy bodies (DLB). This evidence concerns the gene SNCA and Lewy body dementia.